In the initial scientific investigation assessing the prognostic significance of Galectin-3 in acute respiratory failure induced by COVID-19 disease, it emerged as a predictor of mortality, admission to the intensive care unit, and the development of severe ARDS in COVID-19 patients [8]. This evidence concerns the gene LGALS3 and acute respiratory distress syndrome.